Androgen Deprivation Therapy and High Dose Radiotherapy with or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial
R0924 has reached its accrual goal and is closed to accrual, effective June 24th, 2019.
(QOL Sub-study is closed as its accrual goal has been met.)
